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Abstract
Background Epidemiologic research into cancer and
subsequent decision making to reduce the cancer burden in
the population are dependent on the quality of available
data. The more reliable the data, the more conﬁdent we can
be that the decisions made would have the desired effect in
the population. The North American Association of Central
Cancer Registries (NAACCR) certiﬁes population-based
cancer registries, ensuring uniformity of data quality. An
important assessment of registry quality is provided by the
index of completeness of cancer case ascertainment. NA-
ACCR currently computes this index assuming that the
ratio of cancer incidence rates to cancer mortality rates is
constant across geographic areas within cancer site, gender,
and race groups. NAACCR does not incorporate the vari-
ability of this index into the certiﬁcation process.
Methods We propose an improved method for calculating
this index based on a statistical model developed at the
National Cancer Institute to predict expected incidence
using demographic and lifestyle data. We calculate the
variance of our index using statistical approximation.
Results We use the incidence model to predict the num-
ber of new incident cases in each registry area, based on all
available registry data. Then we adjust the registry-speciﬁc
expected numbers for reporting delay and data corrections.
The proposed completeness index is the ratio of the
observed number to the adjusted prediction for each reg-
istry. We calculate the variance of the new index and
propose a simple method of incorporating this variability
into the certiﬁcation process.
Conclusions Better modeling reduces the number of
registries with unrealistically high completeness indices.
We provide a fuller picture of registry performance by
incorporating variability into the certiﬁcation process.
Keywords Data quality   Cancer   Population registers  
Estimation techniques
Introduction and motivation
Cancer surveillance requires a reliable and comprehensive
system for gathering information about newly diagnosed
cancer patients. Epidemiologic research and subsequent
decisions made to improve public health and reduce the
cancer burden in the population are dependent on the
quality of available data. The more reliable the data, the
more conﬁdent we can be that the decisions made would
have the desired effect in the population. The data from
population-based cancer registries are a key component in
any such research. Thus, it is very important to ensure that
these data meets the highest standards of quality and reli-
ability so that researchers may use these data with
conﬁdence and have faith in their analyses.
There is a network of population-based cancer registries
across North America [1] which collect information about
newly diagnosed cancer patients. The North American
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tiﬁes the data collected by these registries and develops
uniform data standards for cancer registration [2]. This is
particularly important as the different registries across
USA and Canada are funded through different mechanisms
and by different agencies, which leads to different collec-
tion methods and processing systems for data [3–5].
NAACCR’s certiﬁcation process ensures that the data meet
essential standards of quality and reliability.
NAACCR assesses the quality of the data collected and
certiﬁes central cancer registries using a variety of criteria.
The index of completeness of incident case ascertainment
by a registry is one vital criterion. A cancer registry may
not be able to collect accurate information on all the
incident cancer cases in its area within the time frame set
for data submission. Some of these cases may be missed
initially but collected later, while some may never be
collected at all. The index of completeness of case ascer-
tainment quantiﬁes the percentage of actual incident cancer
cases that are reported by a registry within the data sub-
mission time frame. The aim is to provide a ranking of
registries with respect to their ability to collect data timely
and accurately. Registries may be certiﬁed by NAACCR as
meeting the gold or silver standard, or as being uncertiﬁed.
In terms of completeness, gold certiﬁcation requires 94%
completeness or higher, while silver requires between 89%
and 94% completeness. Registries having less than 89%
completeness are uncertiﬁed.
The actual number of incident cancer cases in a registry
is an unobserved quantity which must be estimated from
available data. The current NAACCR estimation method-
ology depends on the assumption that the ratio of incidence
to mortality rates is constant across geographic areas for a
given cancer site, race, and gender group.
In this article we propose a new method by which the
assessment of completeness of case ascertainment can be
made more accurate and the certiﬁcation process made
more reliable. In our method, we relax the overly simplistic
assumption of constancy of the incidence-to-mortality rate
ratio. Instead we predict the true incidence in a registry by
a statistical model, incorporating information on geo-
graphic, socio-demographic, health, and lifestyle factors.
We compare this new method with the current NAACCR
method. We also provide an estimate of the variance of the
proposed index and utilize it to suggest a fairer decision-
making process for certiﬁcation. NAACCR does not cal-
culate variance estimates for its current index.
In the next section, we outline the methodology cur-
rently in use at NAACCR to assess the completeness of
case ascertainment and discuss its advantages and disad-
vantages. In subsequent sections we outline our new
methodology for assessment and certiﬁcation and discuss
its impact.
A discussion of the current methodology used by
NAACCR to compute the index of completeness of case
ascertainment
The current NAACCR methodology to estimate the index
of completeness of case ascertainment depends on the
assumption that the ratio of incidence to mortality rates is
approximately constant across geographic areas for a given
cancer site, race, and gender group [6, 7]. For a given
registry, for any one cancer site, gender, and race we can
then calculate
where incidence and mortality are age-adjusted rates for
the same year and SEER is the Surveillance, Epidemiology
and End Results program of the National Cancer Institute
(NCI). The expected registry incidence is then compared to
the observed registry incidence to obtain a cancer site,
gender, and race-speciﬁc completeness index for the reg-
istry. These completeness indices are then weighted by race
and gender, combined, and adjusted for duplicate records
to obtain an overall measure of the completeness of case
ascertainment [8, 9]. NAACCR currently uses race groups
White (W) and Black (B) and 19 cancer sites to calculate
the completeness index. Details of NAACCR’s methodol-
ogy can be found in Appendix 1.
Thus, the current NAACCR methodology essentially
predicts the expected incidence of cancer in a registry
based only on mortality data. However, a variety of other
data are available and known to inﬂuence cancer incidence
rates, such as the proportion of the population that adheres
to recommended cancer screening schedules. NAACCR
makes no attempt to incorporate these data to obtain better
estimates of incidence.
NAACCR does not publish any estimates of the vari-
ance of its estimated completeness index by registry,
although it is known anecdotally that some registries are
Expected Registry Incidence Rate ¼
National Incidence Rate (from SEER)
National Mortality Rate
  Registry Mortality Rate
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123more reliable than others. No use is made of the variability
of the completeness index while certifying a registry. Due
to the natural variability of cancer rates and small numbers
of cases in a small population, a small registry may have
widely variable completeness indices from one year to
another. If the certiﬁcation process does not account for
this variability, their data may be differently certiﬁed from
year to year, giving a possibly false picture of the reliability
and usability of their data, even though the registry is not
statistically signiﬁcantly better or worse. While certiﬁca-
tion is not solely based on the index of completeness, it
remains a very important measure of registry quality, and it
is unsatisfactory that there is no attempt to quantify its
reliability for each registry.
There are known to be delays in cancer incidence data
collection that vary by cancer site. Ideally, a registry would
record and report every primary cancer in its area in a
timely and accurate manner. The SEER registries, for
example, are given 19 months to report all cases for a
given year. However, there is sometimes a delay in
reporting, and new cases will be discovered after the
stipulated submission date. Cancers which tend to be
detected and treated in outpatient settings such as mela-
noma are subject to signiﬁcant delays in reporting because
of the difﬁculty of collecting data in these settings. Occa-
sionally, reported data need to be corrected as new
information is obtained. Obviously, reporting delays and
data corrections affect the reported incidence rates. NA-
ACCR has made no attempt to adjust the expected
incidence ﬁgures used in its method for reporting delays or
corrections. Because of this omission, the NAACCR
method does not have the power to distinguish between
registries that take greater and lesser pains with timeliness
and the correctness of initially reported data.
The current NAACCR method to calculate complete-
ness makes use of data only on the race groups White and
Black. There are clearly drawbacks to excluding other race
groups in the calculation, particularly for registries that
have diverse populations.
Methods
New methodology for predicting cancer incidence and
calculating completeness
Recently, a new methodology has been developed at NCI
[10, 11], which predicts expected incidence based on a
statistical model including geographic, socio-demographic,
health-related, and lifestyle-related data as explanatory
variables. It includes mortality rates as one of many
explanatory variables used and thus can be viewed as an
extension of the NAACCR model. The new model also
includes spatial random effects to account for the similarity
of incidence patterns in neighboring counties, enabling the
sharing of information across regions to obtain better pre-
dictions in sparse data areas. This model has been shown to
provide improved estimates of the number of new cancer
cases than the NAACCR model [12]. Further details of the
model are provided in Appendix 2.
The incidence rates predicted by this model are used as
the expected incidence rates in calculating completeness.
These are used to calculate the race, gender, and cancer-
site-speciﬁc completeness ﬁgures, which are weighted for
race and gender and summed over cancer sites (as in the
NAACCR method) to produce a completeness index for a
registry.
Adjustment for reporting delays and data corrections
NCI has investigated the impact of imperfect reporting on
incidence rates [13, 14] and developed adjustment factors
to be used to obtain reporting adjusted incidence rates.
These delay factors can be obtained from NCI’s Cancer
Query System (available online at http://srab.cancer.gov/
delay/canques.html)
We apply these adjustment factors to predictions from
the NCI incidence model to obtain delay adjusted expected
incidence rates. These adjusted expected incidence rates
were used to calculate the completeness index as outlined
above. By doing this, we have the power to identify reg-
istries which make greater efforts to report correct data in a
timely fashion. Registries that are less timely and accurate
will have observed rates that are smaller percentages of the
adjusted expected incidence rates and thus have lower
completeness indices.
To use the delay factors for all registries, we ﬁrst
adjusted for registry-speciﬁc differences. The registries in
the US are funded by two sources—some are funded
wholly or partially by the SEER program of the NCI, and
some are funded exclusively by the National Program of
Cancer Registries (NPCR) of the Centers for Disease
Control (CDC). This leads to different data collection
procedures and protocols for the two kinds of registries.
Data are currently not available from the NPCR registries
to calculate NPCR-speciﬁc delay factors. Thus, as the
delay factors are derived from SEER data only, they may
not apply directly to NPCR data. However, once an
adjustment is made for funding source, the use of the SEER
delay factors is justiﬁable as all registries can be assumed
equivalent after adjustment. This adjustment was accom-
plished by adding a factor for funding source to the
prediction model. As more data become available from the
NPCR registries to calculate their delay factors directly,
this adjustment will become unnecessary.
Cancer Causes Control (2008) 19:515–525 517
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We calculate the variance of the new index. The variability
in the new index can be partitioned into three parts: a
component due to the variability of the observed incidence
rates, a component due to the variability of the model-
predicted incidence rates and a component accounting for
the variability due to the covariance between the observed
and model predicted rates. Of these three, the largest is that
due to the observed rates as this is the variability of a single
realization of a random quantity. The variability of the
model predicted rates, which are based on larger amounts
of data and are essentially the mean of a number of real-
izations of a random quantity, is relatively small. Both
these terms may be calculated approximately by the delta
method under the assumption of asymptotic normality of
the log rates [15]. The third component is difﬁcult to
compute, but its contribution to the variance is likely to be
small unless the registry is extremely large and contributes
a large proportion of the data used in prediction. Moreover,
the structure of the completeness index, where the observed
rates appear in the numerator and the predicted rates in the
denominator, assures that this covariance term is negative.
Thus omitting this term makes for a more conservative
estimate of the variance. Technical details of the variance
calculation can be found in Appendix 3.
Decision making for certiﬁcation
NAACCR uses its calculated completeness index and some
other criteria to certify the quality of data obtained by each
registry each year. When usingthe new completeness index,
registries would have to meet these criteria for certiﬁcation.
Note that in NAACCR’s method of assigning certiﬁcation
status no use is made of the variability of the completeness
index. By using only the point estimates, i.e., ignoring
variance, in a small registry there can be the appearance of
improvement or deterioration in completeness when in fact
the registry is not statistically signiﬁcantly better or worse.
This is due to the natural variability of cancer rates due to
small numbers of cases in a small population. Conversely,
larger population registries tend to have very stable com-
pleteness indices because of large case counts. Thus it may
appear that they are not making much progress in moving to
a higher certiﬁcation category. If funding decisions are
made on the basis of degree of improvement, for example,
larger registries may lose out unfairly.
We developed a simple method to incorporate the
uncertainty in the completeness index into the certiﬁcation
process. Using the estimate of variance and under the
assumption of asymptotic normality of the new
completeness index, conﬁdence intervals may be calculated
for the completeness index for each registry. This leads to
confusion as to the certiﬁcation status of the registry as
conﬁdence intervals may overlap more than one certiﬁca-
tion interval (Fig. 2). The question then arises as to how to
certify a registry in the presence of information on the
variability of its completeness index. We propose pre-
senting the information on variability by estimating the
probabilities of the registry falling into each certiﬁcation
interval. For each registry we obtain three estimated
probabilities—the chance of being certiﬁed as gold, of
being certiﬁed as silver, and of being uncertiﬁed. Our
certiﬁcation rule is to assign certiﬁcation status to the
registry that has the highest estimated probability. Pre-
senting all the three estimated probabilities gives an idea of
the variability, and registries within each certiﬁcation sta-
tus may be ranked by their probabilities of certiﬁcation.
Data
Data on the observed incidence rates were obtained from
the 1995–2000 CINA Deluxe data set. CINA Deluxe is a
research data ﬁle derived from central cancer registries that
meet NAACCR high data quality criteria (at a minimum of
the silver standard for certiﬁcation) for each diagnosis year
at the time of data submission. Permission to use this data
set was obtained from NAACCR. We only used data from
year 2000. Special permission was obtained from individ-
ual registries to use county-level data in the modeling—not
all registries gave this permission and thus had to be
dropped from our analyses, leaving 29 registries for anal-
ysis (listed in Table 2).
The data on the predictors in the incidence model were
obtained from several sources. Socio-demographic vari-
ables were constructed from census data [16] for urban/
rural status, per capita income, poverty, education, crow-
ded housing, female-headed households, home value,
unemployment, and percent population of minority race/
ethnicity (Asian/Paciﬁc Islander, American Indian/Alaskan
Native, Black, Hispanic origin). The density of the number
of physicians and screening mammogram facilities were
included as measures of availability of relevant medical
services [16]. Lifestyle factors (ever smoked, obesity, no
health insurance, cancer screening) were obtained from
Behavioral Risk Factors Surveillance System (BRFSS), a
nationwide telephone health survey, conducted by the
states and coordinated by the CDC that collects health risk
data. Mortality data were obtained from the National
Center for Health Statistics (NCHS). All variables were
selected from those available at regular intervals for every
US county.
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Both the new index and the index NAACCR uses currently
were calculated for 29 registries on the CINA Deluxe data
set that permitted the use of 2,000 data. Figure 1 shows the
results obtained. For both indices, there are several regis-
tries that exceed 100% completeness. This is undesirable as
it generally shows that the expected incidence rates were ill
predicted for that registry. While it is impossible for any
model to always predict expected rates higher than
observed rates, as no statistical model can be 100% accu-
rate, a good model should do this infrequently. The new
index is an improvement on the NAACCR index, exceed-
ing 100% completeness for 7 of 29 registries as compared
to 14 of 29 for the NAACCR method. Thus the new
method leads to fewer unrealistic indices of above 100%.
We compared the two indices with respect to certiﬁca-
tion (Table 1). Normally, certiﬁcation is based on several
criteria in addition to completeness. However, we do not
have information on all these criteria. Hence, in this
exercise, we have compared ‘‘certiﬁcation’’ status under
the hypothesis that certiﬁcation is based solely on com-
pleteness. This gives us some idea of how the new index
may affect certiﬁcation if used in place of the current
index. Since we have access only to certiﬁed data (silver
standard or higher), it is hard to draw any concrete con-
clusions. There is a slight indication that the new index
may be stricter than the current index as it downgrades
some registries to uncertiﬁed, but it is difﬁcult to be sure as
the two registries that move down to uncertiﬁed status are
both small-population registries with a large proportion of
race groups other than black and white. This is discussed in
greater detail in the next section.
Figure 2 shows the 95% conﬁdence intervals about the
index for each registry. Some intervals are very wide and
cover several certiﬁcation categories as expected, making
assigning a certiﬁcation status difﬁcult. We calculated
certiﬁcation using the new decision-making algorithm
outlined in the methods section (Table 2).
Discussion
The new methodology improves on the current methodol-
ogy in several ways. To ﬁnd the completeness of case
ascertainment by a registry, we need to know the unob-
served true total number of cases for the registry. This must
be estimated from a model under a set of assumptions. The
current NAACCR method uses one such model, where it is
assumed that the ratio of incidence to mortality is a con-
stant across registries for each cancer site. Thus, incidence
is being predicted based on the single covariate mortality.
Furthermore, the model is effectively a constrained one,
due to the assumption of the constancy of the ratio of
incidence to mortality. The new methodology improves on
this model by predicting expected incidence based on many
covariates, including mortality. The prediction is uncon-
strained in the sense that no assumptions are made about
the constancy of model coefﬁcients which are estimated
from available data. The model may be extended and
improved by adding covariates as needed. For example, we
adjusted for registry-speciﬁc funding source differences by
adding as covariate the funding source for each registry,
thus improving the ﬁnal completeness estimates.
The assumption that the ratio of incidence to mortality is
constant across all registries is extremely restrictive as
there is no allowance for spatial variation across the reg-
istries. By adding appropriate error terms to the new
method model we can adjust for any spatial variability that
remains unaccounted for after incorporating all the avail-
able covariates. Such error terms were used at the initial
stages of modeling but were found to be insigniﬁcant and
were dropped from the model. Thus we may be fairly sure
Fig. 1 Comparison of current and proposed completeness indices
with current index adjusted for registry funding source and for
reporting delay and data corrections
Table 1 Comparing certiﬁcation by current and new indices
Certiﬁcation by NAACCR index
Gold Silver None Total
Certiﬁcation by new index Gold 20 2 ? 22
Silver 3 2 ? 5
None 1 1 ? 2
Total 24 5 ? 29
? denotes unknown status due to lack of data
Cancer Causes Control (2008) 19:515–525 519
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over different regions.
We also calculated the variance of the new index. The
variance of the index should be incorporated in the
certiﬁcation process to be fair to all registries. When using
only the point estimates of completeness, the certiﬁcation
status of a registry may be very misleading in case of small
registries where the natural variability of cancer rates due to
Fig. 2 Ninety-ﬁve percent
conﬁdence intervals about the
new completeness index for
each registry
Table 2 Results of certifying
by new algorithm
a Denotes those registries
which are certiﬁed differently
using the current index and the
current algorithm. The results
for AK and AZ are discussed
further in the text and may not
be reliable
Registry P(Gold) P(Silver) P(Uncertiﬁed) New result Current result
AK
a 6.94 32.48 60.58 Uncertiﬁed Gold
AZ
a 0.00 43.58 56.42 Uncertiﬁed Silver
CA 100.00 0.00 0.00 Gold Gold
CT 100.00 0.00 0.00 Gold Gold
FL 100.00 0.00 0.00 Gold Gold
ATL(Atlanta) 98.59 1.41 0.00 Gold Gold
HI 98.29 1.71 0.00 Gold Gold
ID 99.99 0.01 0.00 Gold Gold
IA 99.95 0.05 0.00 Gold Gold
KY 100.00 0.00 0.00 Gold Gold
LA 99.76 0.24 0.00 Gold Gold
DET(Detroit) 100.00 0.00 0.00 Gold Gold
MT 78.95 16.95 4.10 Gold Gold
NE 99.99 0.01 0.00 Gold Gold
NH
a 18.33 67.25 14.42 Silver Gold
NJ 100.00 0.00 0.00 Gold Gold
NM 20.68 74.39 4.93 Silver Silver
NC
a 12.51 87.49 0.00 Silver Gold
ND
a 66.64 27.11 6.25 Gold Silver
OR 99.93 0.07 0.00 Gold Gold
PA 99.99 0.01 0.00 Gold Gold
RI 99.99 0.01 0.00 Gold Gold
SC
a 82.32 17.68 0.00 Gold Silver
UT 35.89 61.83 2.28 Silver Silver
WA 100.00 0.00 0.00 Gold Gold
STL(Seattle) 100.00 0.00 0.00 Gold Gold
WV 99.88 0.12 0.00 Gold Gold
WI
a 0.02 85.04 14.94 Silver Gold
WY 80.17 17.91 1.92 Gold Gold
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falsely inﬂated certiﬁcation status. Conversely, larger popu-
lation registries, which tend to have very stable completeness
indices because of large case counts, may be penalized for an
apparentlackofprogress.Ineithercase,researcherscannotbe
fully conﬁdent that the certiﬁcation process has captured all
the elements of the quality of the data and cannot be entirely
sure of their analyses based on that data. Because standard
conﬁdence intervals are somewhat confusing to interpret in
thiscontext, we haveproposeda simpleway ofincorporating
variability in the certiﬁcation process.
The new method also accounts for the timeliness and
accuracy of incident case reporting by a registry when
calculating completeness. Registries that take care to report
data timely and accurately should be credited for their
efforts. Because the underlying incidence prediction model
is ﬂexible and allows for adjustment, we were able to
couple it with the delay and correction factors derived from
SEER registry data to approximately identify timely reg-
istries. This results in an index that is more realistic and
philosophically more satisfying. It would be better if we
were able to derive delay and correction factors based on
NPCR data as well, but currently not enough data are
available to do this as the records for NPCR registries are
not long enough. We do expect to have such data in the
future and should be able to improve the corrections done
to the expected incidence to account for delay.
We note here that NAACCR only looks at the accuracy
and timeliness of data at a single time point for certiﬁca-
tion. Ideally, registries should ﬁnd all cases in their
catchment area within the speciﬁed time. This goal is
however somewhat impractical in cases of cancers which
are mostly treated in the outpatient setting. Thus, registries
should be encouraged to collect data on cases that they
missed within the initial deadline for data submission.
Registries which put effort into this, will, over several
years, have more accurate and complete data for
researchers, even if some cases were missed initially.
Currently NAACCR does not have any mechanism in place
to identify and reward such registries. In the interests of
high-quality data, some sort of re-certiﬁcation procedure
seems to be called for.
The current and the new indices are based only on White
and Black data. It may be more desirable to calculate the
index based on all races combined for small population
registries with a large proportion of their population in
races other than Black and White. For such small registries,
the case counts are likely to be small, particularly for rarer
cancers. In this situation, if a proportion of the cases are
further eliminated because they occur in race groups other
than Black and White, the case counts may become very
small, making the overall index unnecessarily much more
variable and uncertain and may lead to unreliable
certiﬁcation results. For example, in Table 2, AK drops to
uncertiﬁed from gold, which is probably a reﬂection of the
fact that it has a small population with a large proportion of
race groups that are non-Black and non-White rather than
the quality of the case collecting efforts of the registry. The
same may also be true of AZ.
A limitation of the new index is that it requires more
computationtoestimatetheexpectedincidence.However,the
extra work to compute the expected incidences can be per-
formedoncecentrally and neednot bea burdenon individual
registries.Thusindividualregistrieswouldbeabletocalculate
their completenessindex exactlyastheydonow byobtaining
their pre-calculated expected values from a central data set.
In conclusion, statistical modeling predicts expected
incidence using a more objective model, based on more
information than the current incidence to mortality ratio
based method. The new method is more ﬂexible than the
current method and can be easily modiﬁed to include fur-
ther predictors or adjust for new information if needed. In
particular, adjusting for differences between SEER-NPCR
and NPCR-only funded registries and for reporting delay
and data corrections helps to reduce unrealistic over 100%
completeness index values.
We have calculated the variance of our index and
demonstrated a method of integrating the uncertainty of the
index in the certiﬁcation process. We feel this is important
to get a fuller picture of registry quality.
The new index may certify a registry differently from the
currentmethod.Itishardtodrawﬁrmerconclusionsworking
withonlycertiﬁeddata.Infuture,ifwecanobtainpermission
tousesuchdata,wewouldbeinterestedinlookingatthefull
impact of the method change on certiﬁcation decisions for
registries both certiﬁed and uncertiﬁed.
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Appendix 1: An outline of the methodology currently
used by NAACCR to compute the index of
completeness-of-case ascertainment
In this appendix we describe the method currently adopted
by NAACCR to quantify the completeness-of-case ascer-
tainment. The decisions inherent in this method, such as
choice of data sets, assumptions made, race groups used,
assumed values of constants, and so on, were decided solely
by NAACCR. For more details on this method, see [8].
Basic principles
The current NAACCR methodology to estimate the index
of completeness of case ascertainment depends on the
Cancer Causes Control (2008) 19:515–525 521
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approximately constant across geographic areas for a given
cancer site, race, and gender group [6, 7]. The stability of
this ratio is exploited to estimate the expected incidence in
a geographic area (e.g., a registry). The basic relationship
for a registry, for any one cancer site, gender, and race can
be written as
Expected Registry Incidence
¼
NationalIncidenceðfromSEERÞ
National Mortality
  Registry Mortality
where incidence and mortality are age-adjusted rates for
the same year and SEER is the Surveillance, Epidemiology
and End Results program of the National Cancer Institute
(NCI). To ensure stability, registry-level mortality is
adjusted as we shall detail later. The expected registry
incidence is then compared to the observed registry inci-
dence to obtain a site, gender, and race-speciﬁc
completeness index for the registry. These completeness
indices are then weighted, combined, and adjusted for
duplicate records to obtain an overall measure of the
completeness of case ascertainment [8, 9]. NAACCR cur-
rently uses race groups White (W) and Black (B), and 19
cancer sites to calculate the completeness index.
Registry-level mortality is adjusted for stability before
using calculating the registry-level expected incidence. To
perform the adjustments, each registry collects the fol-
lowing data in its catchment region:
1. The age-adjusted incidence rate for the reporting year
for each site, gender, and race. This is the Observed
Incidence Rate (OIR).
2. The age-adjusted two-year annual average mortality
rate for each site, gender, and race. This is the Current
Mortality Rate (CMR). If the registry population is
below 500,000, the three year average mortality rate is
used.
3. The age-adjusted ﬁve-year annual average mortality
rate for each site, gender, and race. This is the
Reference Mortality Rate (RMR).
4. The observed number of incident cases (OI) for the
reporting year.
5. The percentage of duplicate data records (DUP).
Adjusting CMR for case fatality
The CMR is ﬁrst adjusted for the local case-fatality ratio.
The case-fatality ratio for a given cancer site is the ratio of
the number of people who die of the cancer to the number
of incident cases of the cancer. Differences between the
registry and national-level case-fatality ratios may artiﬁ-
cially inﬂuence the estimated expected incidence, unless
adjusted for. For example, if more people die in a particular
area without a rise in the number of incident cases as
compared to the nation, i.e., the area has a higher case-
fatality ratio than the nation, the estimated expected inci-
dence obtained by the basic relationship outlined above
would be falsely inﬂated. Thus, in this case, the CMR must
be deﬂated to ensure the local incidence-to-mortality rate
ratio can be considered approximately equal to the national
incidence to mortality rate ratio.
To do this, the age-adjusted ﬁve-year average U.S
Mortality Rate (USMR) for the given cancer site, race, and
gender is compared to the RMR. The difference between
the RMR and USMR is attributable to several causes,
including deterministic factors and random variation.
NAACCR assumes that a proportion a of the standardized
difference between the two mortality rates is due to dif-
ferential case fatality, and the CMR is adjusted accordingly
to get the Adjusted Current Mortality Rate (ACMR) in the
given site, gender, and race group. Thus, if
Standardized difference between
national and local mortality rates
¼ f ¼
RMR   USMR
RMR
the Adjusted Current Mortality Rate (ACMR) is
ACMR ¼ð 1   afÞCMR.
If a is 0, i.e., we attribute none of the differences
between the RMR and USMR to differential case fatality,
ACMR equals CMR. If a is 1, i.e., we attribute the entire
difference between the RMR and USMR to differential
case fatality,
ACMR ¼
USMR
RMR
  CMR:
The adjustment to the mortality rate is by cancer site,
allowing for different case fatalities for different cancers.
It is also possible to choose different a values for dif-
ferent cancer sites according to whether the case-fatality
ratio is higher or lower than the national average. Currently
a is ﬁxed by NAACCR at 0.2 for all sites, genders, races,
and registries, i.e., 20% of the difference between RMR
and USMR is attributed to differential case fatality.
The Expected Registry-Speciﬁc Age-Adjusted Incidence
Rate (EIR) for the given cancer site, gender, and race is
then obtained (by using the basic relationship) as
EIR ¼
SIR
USMR
  ACMR
where SIR = age-adjusted ﬁve-year average SEER
incidence rate.
Obtaining the registry speciﬁc index of completeness of
case ascertainment
Once EIRs have been calculated for each cancer site, sex,
and race, interim percentage completeness (ICgr, where g is
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white (W) or black (B)) is calculated for each race-gender
combination as
ICgr ¼
P
site
OIRgr;site
P
site
EIRgr;site
:
Next, the ICgrs are weighted and combined over gender
to give race-speciﬁc indices. The combination weights are
based on the population proportions of the two genders in
each race group. Currently NAACCR uses data on races
White and Black only to calculate the index and ignores
data collected on other race groups by a registry. The
consequences of ignoring data on races other than Black
and White are examined in the discussion section. A
similar adjustment is then done to combine the race-
speciﬁc completeness indices CW and CB, using population
weights, to obtain the Race Proportional Completeness
Index (RPC) for the registry.
To obtain the ﬁnal completeness index (C) for registry,
duplicate records are taken into account. We obtain the
adjusted observed and expected number of incident cases
(AOI and AEI, respectively) for a registry as
AOI ¼
ð100   DupÞ
100
  OI:
AEI ¼
OI
RPC
Then
C ¼
AOI
AEI
  100:
In the absence of duplicate records, C = RPC.
This process is repeated to obtain registry-speciﬁc
completeness indices for all registries in North America.
Appendix 2 : The spatial prediction model for cancer
incidence
The number of new cancer cases in county i (i = 1,...,I),
age group j (j = 1,...,J), registry k (k = 1,...,17), region r
(r = 1,2,3,4 deﬁning Census Regions Northeast (NE),
Midwest (MW), South (S), and West (W), respectively),
denoted dij[kr], is assumed to be Poisson distributed, with
mean nij[kr]kij[kr] and variance /nij[kr]kij[kr], where nij[kr] is
the corresponding population at risk and / measures
overdispersion beyond the standard Poisson variance.
(Subscripts k and r are bracketed because they are super-
ﬂuous, i.e., they are uniquely determined by county i.) We
further assume a log-linear rate structure, i.e.,
lnðkij½kr Þ¼b0i½r  þ fðajÞb þ mij½kr c þ X0
i½kr d ð1Þ
where aj is the centered midpoint of age group j, mij[kr]
is the logarithm of the mortality rate for county i, age group
j, Xi[kr] is a p-dimensional vector of covariates for county i
and b, c and d are parameters to be estimated. A cubic
function of centered ages (f(aj)) was necessary to accom-
modate downturns in some cancer rates at the oldest ages.
The county intercepts, b0i[r], are considered to be normally
distributed random effects of available counties within
each region with mean vector b0 (r 9 1) and variance
matrix
P
, where
P
incorporates a spatial covariance
structure as necessary.
The following variables were included as predictors in
the model:
Age: age (0–4, 5–14, 15–24,…,75–84, 85+), age
2, age
3
(centered);
Year: year, year
2, year
3 (centered)—included for full
time span, although only the results for year 2000 are
used for the completeness analysis;
Race: Black, Other (White = referent);
Log mortality rate;
Ethnicity/origin: % Hispanic, Black, Asian/Paciﬁc
Islander, American Indian/Alaskan Native;
Medical facilities: number of physicians and mammo-
gram screening facilities per 1,000 population;
Household characteristics: % female head of household,
% households with an average of more than 1 person per
room;
Socioeconomic status:
Income: median per capita income, % persons living
below the federal poverty level;
Education: % persons ages 25 and over with less than
nine years of education and % with 4+ years of college;
Other: % unemployment;
Urban/rural indicators: urban/rural continuum code [17]
grouped into 5 categories, population density;
Geography: Census Region (Northeast, Midwest, South,
West), latitude, longitude;
Lifestyle: % adults who ever smoked at least 100
cigarettes, % adults at risk of obesity (body mass
index[120% of sample median), % women ages 50–64
who had had mammogram during the last two years, %
adults with no health insurance (note that because of
collinearity, mammography use and obesity could not be
included in the same model);
Cancer registry system: NCI/SEER or CDC/NPCR.
The model parameters were estimated using the SAS
GLIMMIX macro for PROC MIXED. All two-factor
interactions were included in an initial model; nonsigniﬁ-
cant interactions and main effects were removed by a
backwards stepwise regression process prior to application
of the spatial model.
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more restricted input dataset consisting of 1999–2001 data
from the 17 SEER registries (see http://seer.cancer.gov/ for
deﬁnitions). Results from the spatial model described
above (excluding the time covariate) and corresponding
results derived from the same method used by NAACCR
for the four major cancer sites were compared to the
numbers of cases reported by each registry in the U.S.
Cancer Statistics Report for each of the three years 1999–
2001 [18–20]. The measure of closeness of each estimate to
the reported ﬁgure was the sum of squared deviations at the
state level (i.e., (estimated #-reported #)
2, summed over
all available states). Results (Table 3) showed either that
the methods gave similar results (lung and colon cancer) or
that the new spatial model was much better (lower sum)
than the previous method (breast and prostate cancer) [see
11, 12].
Appendix 3: Calculating the variance of the new
completeness index
The delta method [see 15] may be used to calculate the
variance of the new index under the assumption that the
logarithm of the age-speciﬁc rates for each race, gender,
and cancer site is normally distributed. This assumption we
have already made in order to perform the incidence
modeling and thus, no new assumption is speciﬁcally
needed for calculating the variance. Thus assume
argsa ¼ logðkrgsaÞfollows Nðlrgsa;r2
rgsaÞð 1Þ
where r denotes race, g denotes gender, s denotes cancer
site and a denotes age group and k denotes incidence rate.
The age adjusted rate can then be written as
age adjusted rate ¼ grgs ¼
X
a
wage
a eargsa
where wage
a is the standard population weight associated
with the age group a.
Then, the completeness index Cq for a registry q can be
written as
Cq ¼
X
r
wrace
r
X
g
wgender
gr
P
s
P
a
wage
a k
obs
rgsa
P
s
P
a
w
age
a eargsa
where k
obs is the observed age speciﬁc incidence rate in
the appropriate age, race, gender, and cancer site group,
wrace
r is the population-based weight for the rth race
category; and wgender
gr is the population-based weight for the
gender g within race group r. Note that, parallel to (1) we
can assume
aobs
rgsa ¼ logðk
obs
rgsaÞfollows Nðlobs
rgsa;ðrobs
rgsaÞ
2Þð 2Þ
We note here that Cq is a function of observed
(numerator term) and expected (denominator term)
incidence rates so if O denotes the set of observed
incidence rates and E denotes the set of expected
incidence rates we can write the completeness index as
Cq ¼ FðO;EÞ
In that case, by the delta method, the variance of Cq can
be written symbolically as
VarðCqÞ¼½ F
0
OðO;EÞ 
TROOF
0
OðO;EÞ
þ½ F
0
EðO;EÞ 
TREEF
0
EðO;EÞ
þ 2½F
0
OðO;EÞ 
TROEF
0
EðO;EÞ
where F
0
X denotes the derivative of F with respect to the set
of variables X and RXY is the covariance matrix of the set of
variables X and Y. The third term in the above equation
involves the covariances between the model predicted rates
and the observed rates. This is likely to be small unless the
registry q is very large and contributes a large amount of
the observed data in the model, dominating other registries.
Thus, for a small registry, the covariances would be small
and the third term could be neglected. Note that due to the
form of the completeness index with the observed rates in
the numerator and the expected rates in the denominator,
and the fact that observed and predicted rates are positively
correlated implies the third term is negative. Thus, omitting
the third term even in the case of a large registry would
make the estimate of the variance of the completeness
index to be larger (more conservative). Using assumptions
(1) and (2) and repeated applications of the delta method,
we can then calculate a conservative estimate of the vari-
ance of the completeness index.
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